biote Statistics
Total Valuation
biote has a market cap or net worth of $36.95 million. The enterprise value is $155.92 million.
| Market Cap | 36.95M |
| Enterprise Value | 155.92M |
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
biote has 33.90 million shares outstanding. The number of shares has decreased by -20.90% in one year.
| Current Share Class | 28.68M |
| Shares Outstanding | 33.90M |
| Shares Change (YoY) | -20.90% |
| Shares Change (QoQ) | -4.23% |
| Owned by Insiders (%) | 19.43% |
| Owned by Institutions (%) | 38.94% |
| Float | 16.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 145.33 |
| PS Ratio | 0.21 |
| Forward PS | 0.21 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.99 |
| P/OCF Ratio | 2.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.62, with an EV/FCF ratio of 21.05.
| EV / Earnings | n/a |
| EV / Sales | 0.87 |
| EV / EBITDA | 12.62 |
| EV / EBIT | 16.18 |
| EV / FCF | 21.05 |
Financial Position
The company has a current ratio of 1.37
| Current Ratio | 1.37 |
| Quick Ratio | 0.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | 9.51 |
| Debt / FCF | 17.25 |
| Interest Coverage | 1.10 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 5.65% |
| Return on Invested Capital (ROIC) | -6.66% |
| Return on Capital Employed (ROCE) | 13.53% |
| Weighted Average Cost of Capital (WACC) | 0.49% |
| Revenue Per Employee | $802,283 |
| Profits Per Employee | -$8,632 |
| Employee Count | 223 |
| Asset Turnover | 1.68 |
| Inventory Turnover | 3.29 |
Taxes
In the past 12 months, biote has paid $4.74 million in taxes.
| Income Tax | 4.74M |
| Effective Tax Rate | 149.34% |
Stock Price Statistics
The stock price has decreased by -55.69% in the last 52 weeks. The beta is 1.74, so biote's price volatility has been higher than the market average.
| Beta (5Y) | 1.74 |
| 52-Week Price Change | -55.69% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 1.78 |
| Relative Strength Index (RSI) | 45.47 |
| Average Volume (20 Days) | 95,354 |
Short Selling Information
The latest short interest is 1.18 million, so 3.48% of the outstanding shares have been sold short.
| Short Interest | 1.18M |
| Short Previous Month | 1.08M |
| Short % of Shares Out | 3.48% |
| Short % of Float | 7.17% |
| Short Ratio (days to cover) | 8.62 |
Income Statement
In the last 12 months, biote had revenue of $178.91 million and -$1.93 million in losses. Loss per share was -$0.07.
| Revenue | 178.91M |
| Gross Profit | 120.78M |
| Operating Income | 9.63M |
| Pretax Income | 3.17M |
| Net Income | -1.93M |
| EBITDA | 12.36M |
| EBIT | 9.63M |
| Loss Per Share | -$0.07 |
Balance Sheet
The company has $8.85 million in cash and $127.83 million in debt, with a net cash position of -$118.97 million or -$3.51 per share.
| Cash & Cash Equivalents | 8.85M |
| Total Debt | 127.83M |
| Net Cash | -118.97M |
| Net Cash Per Share | -$3.51 |
| Equity (Book Value) | -57.60M |
| Book Value Per Share | -2.41 |
| Working Capital | 11.26M |
Cash Flow
In the last 12 months, operating cash flow was $13.98 million and capital expenditures -$6.57 million, giving a free cash flow of $7.41 million.
| Operating Cash Flow | 13.98M |
| Capital Expenditures | -6.57M |
| Depreciation & Amortization | 2.72M |
| Net Borrowing | 90.09M |
| Free Cash Flow | 7.41M |
| FCF Per Share | $0.22 |
Margins
Gross margin is 67.51%, with operating and profit margins of 5.38% and -1.08%.
| Gross Margin | 67.51% |
| Operating Margin | 5.38% |
| Pretax Margin | 1.77% |
| Profit Margin | -1.08% |
| EBITDA Margin | 6.91% |
| EBIT Margin | 5.38% |
| FCF Margin | 4.14% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 20.90% |
| Shareholder Yield | 20.90% |
| Earnings Yield | -6.03% |
| FCF Yield | 20.05% |
Analyst Forecast
The average price target for biote is $2.22, which is 104.04% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.22 |
| Price Target Difference | 104.04% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 0.82% |
| EPS Growth Forecast (3Y) | -3.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 1.78 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.78 |
| Piotroski F-Score | 4 |